Hidetoshi Fukuoka

Prognosis of patients with hepatocellular carcinoma after hepatic resection: Are elderly patients suitable for surgery?

Atsushi Nanashima, Takafumi Abo, Takashi Nonaka et al. · Journal of Surgical Oncology · 2011 · 89 citations

Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer.

Takashi Tsuji, Shigekazu Hidaka, Terumitsu Sawai et al. · PubMed · 2003 · 80 citations

Tumor Biology, Oncology, Efficacious Marker +15

Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma

Atsushi Nanashima, Yorihisa Sumida, Takafumi Abo et al. · Journal of Surgical Oncology · 2008 · 62 citations

Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy

Atsushi Nanashima, Yorihisa Sumida, Takafumi Abo et al. · Journal of Gastroenterology · 2006 · 44 citations

Surgical Oncology, Hepatology, Hepatocellular Carcinoma Patients +9

No association of mouse mammary tumor virus‐related retrovirus with Japanese cases of breast cancer

Hidetoshi Fukuoka, Masako Moriuchi, Hiroshi Yano et al. · Journal of Medical Virology · 2008 · 44 citations

Breast Oncology, Molecular Virology, Medicine +13